World health organization

10 facts on immunization

A woman being vaccinated during a pilot campaign for the new meningococcal A conjugate vaccine, Burkina Faso.
WHO/R. Barry

Public-private partnerships facilitate the development and introduction of vaccines

For example, a new vaccine which prevents the primary cause of epidemic meningitis in sub-Saharan Africa, meningococcal A, MenAfriVac, was introduced in Burkina Faso, Mali and Niger last year. At the end of 2011. Cameroon, Chad and Nigeria are vaccinating more than 22 million individuals with the vaccine which has the potential to eliminate the leading cause of meningitis epidemics in Africa.

© WHO. All rights reserved.